Honest Peptide is not a compounding pharmacy or chemical compounding facility as defined under section 503A of the Federal Food, Drug, and Cosmetic Act, nor an outsourcing facility as defined under section 503B
No completed large-scale clinical evidence currently establishes MOTS-C as a safe and effective weight-loss medication
Success in this environment requires adaptability, compliance infrastructure, and realistic risk assessment
Frontiers in Endocrinology
Mots-c regulates Ros/txnip/nlrp3 pathway and alleviates myocardial damage in diabetic rats: 433
Common side effects include nausea, headaches, fluid retention, and injection-site irritation, per Chicago Arthritis and Couture Med Spa